Clinical and Experimental Reproductive Medicine

The Korean Society for Reproductive Medicine (대한생식의학회)
권호 표지
DOI QR코드

DOI QR Code

Adverse pregnancy outcomes with assisted reproductive technology in non-obese women with polycystic ovary syndrome: a case-control study

  • Han, Ae-Ra (Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Cheil General Hospital, Kwandong University College of Medicine) ;
  • Kim, Hye-Ok (Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Cheil General Hospital, Kwandong University College of Medicine) ;
  • Cha, Sun-Wha (Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Cheil General Hospital, Kwandong University College of Medicine) ;
  • Park, Chan-Woo (Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Cheil General Hospital, Kwandong University College of Medicine) ;
  • Kim, Jin-Yeong (Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Cheil General Hospital, Kwandong University College of Medicine) ;
  • Yang, Kwang-Moon (Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Cheil General Hospital, Kwandong University College of Medicine) ;
  • Song, In-Ok (Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Cheil General Hospital, Kwandong University College of Medicine) ;
  • Koong, Mi-Kyoung (Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Cheil General Hospital, Kwandong University College of Medicine) ;
  • Kan, Inn-Soo (Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Cheil General Hospital, Kwandong University College of Medicine)
  • Received : 2011.02.15
  • Accepted : 2011.04.21
  • Published : 2011.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: To investigate adverse pregnancy outcomes in non-obese women with polycystic ovary syndrome (PCOS) compared with obese-PCOS and control groups. Methods: Women with PCOS who underwent assisted reproductive technology (ART) from August, 2003 to December, 2007, were considered. A total of 336 women with PCOS were included in the study group and 1,003 infertile women who had tubal factor as an indication for ART were collected as controls. They were divided into four groups: a non-obese PCOS group, obese-PCOS group, non-obese tubal factor group, and obese tubal factor group, with obesity defined by a body mass index over 25 kg/$m^2$, and reviewed focusing on the basal characteristics, ART outcomes, and adverse pregnancy outcomes. Results: There was no difference among the groups' the clinical pregnancy rate or live birth rate. Regarding adverse pregnancy outcomes, the miscarriage rate, multiple pregnancy rate, and prevalence of preterm delivery and pregnancy induced hypertension were not different among the four groups. The incidence of small for gestational age infant was higher in the PCOS groups than the tubal factor groups ($p$ <0.02). On the other hand, the morbidity of gestational diabetes mellitus (GDM) was not high in the non-obese PCOS group but was in the obese groups. And in the obese PCOS group, the newborns were heavier than in the other groups ($p$ <0.02). Conclusion: Non-obese PCOS presents many differences compared with obese PCOS, not only in the IVF-parameters but also in the morbidity of adverse pregnancy outcomes, especially in GDM and fetal macrosomia.

Keywords

References

  1. Franks S. Polycystic ovary syndrome. N Engl J Med 1995;333:853-61. https://doi.org/10.1056/NEJM199509283331307
  2. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-7. https://doi.org/10.1093/humrep/deh098
  3. Dunaif A. Insulin action in the polycystic ovary syndrome. Endocrinol Metab Clin North Am 1999;28:341-59. https://doi.org/10.1016/S0889-8529(05)70073-6
  4. Barker DJ. Maternal and fetal origins of coronary heart disease. J R Coll Physicians Lond 1994;28:544-51.
  5. Boomsma CM, Eijkemans MJ, Hughes EG, Visser GH, Fauser BC, Macklon NS. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update 2006;12:673-83. https://doi.org/10.1093/humupd/dml036
  6. Boomsma CM, Fauser BC, Macklon NS. Pregnancy complications in women with polycystic ovary syndrome. Semin Reprod Med 2008;26:72-84. https://doi.org/10.1055/s-2007-992927
  7. Laven JS, Imani B, Eijkemans MJ, Fauser BC. New approach to polycystic ovary syndrome and other forms of anovulatory infertility. Obstet Gynecol Surv 2002;57:755-67. https://doi.org/10.1097/00006254-200211000-00022
  8. Urman B, Sarac E, Dogan L, Gurgan T. Pregnancy in infertile PCOD patients: complications and outcome. J Reprod Med 1997;42:501-5.
  9. Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care 1998;21 Suppl 2:B161-7.
  10. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. Geneva (CH): WHO; 1998.
  11. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983;67:968-77. https://doi.org/10.1161/01.CIR.67.5.968
  12. Deurenberg-Yap M, Yian TB, Kai CS, Deurenberg P, van Staveren WA. Manifestation of cardiovascular risk factors at low levels of body mass index and waist-to-hip ratio in Singaporean Chinese. Asia Pac J Clin Nutr 1999;8:177-83. https://doi.org/10.1046/j.1440-6047.1999.00091.x
  13. The World Health Organization Western Pacific Region. The international Association for the Study of Obesity, and The international Force. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia Pty Limited; 2000.
  14. Korea Centers for Disease Control and Prevention. The Republic of Korea's national nutritional survey of 2008 [Internet]. Seoul: Korea Centers for Disease Control and Prevention; 2010 [cited 2011 May 10]. Available from: http://knhanes.cdc.go.kr.
  15. Qiao J, Feng HL. Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence. Hum Reprod Update 2011;17:17-33. https://doi.org/10.1093/humupd/dmq032
  16. Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Roberts KA, Nestler JE. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab 2002;87:524-9. https://doi.org/10.1210/jc.87.2.524
  17. Homburg R, Armar NA, Eshel A, Adams J, Jacobs HS. Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. BMJ 1988;297:1024-6. https://doi.org/10.1136/bmj.297.6655.1024
  18. Dickey RP, Taylor SN, Curole DN, Rye PH, Pyrzak R. Incidence of spontaneous abortion in clomiphene pregnancies. Hum Reprod 1996;11:2623-8. https://doi.org/10.1093/oxfordjournals.humrep.a019182
  19. Wang JX, Davies MJ, Norman RJ. Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment. Hum Reprod 2001;16:2606-9. https://doi.org/10.1093/humrep/16.12.2606
  20. Mikola M, Hiilesmaa V, Halttunen M, Suhonen L, Tiitinen A. Obstetric outcome in women with polycystic ovarian syndrome. Hum Reprod 2001;16:226-9.
  21. Manikkam M, Crespi EJ, Doop DD, Herkimer C, Lee JS, Yu S, et al. Fetal programming: prenatal testosterone excess leads to fetal growth retardation and postnatal catch-up growth in sheep. Endocrinology 2004;145:790-8. https://doi.org/10.1210/en.2003-0478
  22. Sir-Petermann T, Hitchsfeld C, Maliqueo M, Codner E, Echiburú B, Gazitúa R, et al. Birth weight in offspring of mothers with polycystic ovarian syndrome. Hum Reprod 2005;20:2122-6. https://doi.org/10.1093/humrep/dei009

Cited by

  1. Genome-wide association study identifies GYS2 as a novel genetic factor for polycystic ovary syndrome through obesity-related condition vol.57, pp.10, 2011, https://doi.org/10.1038/jhg.2012.92
  2. Letter to the Editor: A cohort study and not a case control study vol.39, pp.3, 2011, https://doi.org/10.5653/cerm.2012.39.3.125
  3. The Author Response: A cohort study and not a case control study vol.39, pp.3, 2011, https://doi.org/10.5653/cerm.2012.39.3.126
  4. Pregnancy Outcome of Multiparous Women Aged over 40 Years vol.2013, pp.None, 2011, https://doi.org/10.1155/2013/287519
  5. Obstetric complications in women with polycystic ovary syndrome: a systematic review and meta-analysis vol.11, pp.None, 2011, https://doi.org/10.1186/1477-7827-11-56
  6. A retrospective study of the pregnancy, delivery and neonatal outcome in overweight versus normal weight women with polycystic ovary syndrome vol.29, pp.10, 2011, https://doi.org/10.1093/humrep/deu154
  7. Unaltered timing of embryo development in women with polycystic ovarian syndrome (PCOS): a time-lapse study vol.32, pp.7, 2015, https://doi.org/10.1007/s10815-015-0488-0
  8. Complications and challenges associated with polycystic ovary syndrome: current perspectives vol.7, pp.None, 2011, https://doi.org/10.2147/ijwh.s70314
  9. Pregnancy complications in women with polycystic ovary syndrome vol.21, pp.5, 2011, https://doi.org/10.1093/humupd/dmv029
  10. The freezing method of cleavage stage embryos has no impact on the weight of the newborns vol.33, pp.3, 2011, https://doi.org/10.1007/s10815-015-0642-8
  11. Pregnancy complications in spontaneous and assisted conceptions of women with infertility and subfertility factors. A comprehensive review vol.33, pp.5, 2011, https://doi.org/10.1016/j.rbmo.2016.08.007
  12. Comparison of In Vitro Fertilization/Intracytoplasmic Sperm Injection Cycle Outcome in Patients with and without Polycystic Ovary Syndrome: A Modified Poisson Regression Model vol.11, pp.4, 2011, https://doi.org/10.22074/ijfs.2018.5117
  13. Polycystic ovary syndrome throughout a woman’s life vol.35, pp.1, 2011, https://doi.org/10.1007/s10815-017-1047-7
  14. Polycystic ovary syndrome and risk factors for gestational diabetes vol.7, pp.7, 2011, https://doi.org/10.1530/ec-18-0076
  15. Pregnancy complications in infertile patients with polycystic ovary syndrome: updated evidence vol.70, pp.6, 2011, https://doi.org/10.23736/s0026-4784.18.04230-2
  16. Pre-Conception Characteristics Predict Obstetrical and Neonatal Outcomes in Women With Polycystic Ovary Syndrome vol.104, pp.3, 2011, https://doi.org/10.1210/jc.2018-01787
  17. Fas and FasL genetic polymorphisms in women with recurrent pregnancy loss: a case-control study vol.22, pp.3, 2019, https://doi.org/10.1080/14647273.2018.1467573
  18. Misuse of testosterone replacement therapy in men in infertile couples and its influence on infertility treatment vol.46, pp.4, 2011, https://doi.org/10.5653/cerm.2019.00290
  19. Overweight, obesity and hyperandrogenemia are associated with gestational diabetes mellitus: A follow‐up cohort study vol.99, pp.10, 2011, https://doi.org/10.1111/aogs.13883
  20. Blood pressure and hypertension during pregnancy in women with polycystic ovary syndrome: Odense Child Cohort vol.99, pp.10, 2020, https://doi.org/10.1111/aogs.13914
  21. Fetal growth, fetal development, and placental features in women with polycystic ovary syndrome: analysis based on fetal and placental magnetic resonance imaging vol.21, pp.12, 2020, https://doi.org/10.1631/jzus.b2000350
  22. Women with PCOS with a History of Early Pregnancy Loss Show a Higher Risk of Gestational Diabetes Mellitus vol.14, pp.None, 2021, https://doi.org/10.2147/ijgm.s334666
  23. Update on polycystic ovary syndrome vol.48, pp.3, 2011, https://doi.org/10.5653/cerm.2020.04329